The ubiquitous transcriptional co-activators Yap (gene symbol Yap1) and Taz (gene symbol 36 Wwtr1) regulate gene expression mainly by co-activating the Tead transcription factors. 37
The fact that energy stress and the key exercise kinase AMPK regulate Yap suggest that 243
Yap should be affected by exercise and diet. This now needs to be demonstrated in an 244 exercise model. Also, because Hippo signalling responds to glucose and regulates the 245 expression of glucose transporters (145), it should be studied whether Hippo signalling 246 mediates the augmented adaptations in response endurance training under low 247 carbohydrate supply (12), or mediates some of the anti-diabetic effects of exercise. 248 249
Cross-talk with hypoxia signalling 250
During evolution, the rise in atmospheric oxygen was followed by the evolution of oxidative 251 phosphorylation by mitochondria, which use oxygen as their main electron acceptor. The 252 emergence of oxygen-related metabolism drove the evolution of oxygen-sensing systems, 253 as oxygen became critical for survival. Oxygen-sensing systems allow cells and organisms 254 to adapt to low oxygen levels (i.e., hypoxia) especially through the transcription factor 255 hypoxia-inducible factor (Hif1). Hypoxic conditions lead to an increase in the expression 256 levels of the Hif1α isoform by blocking its degradation. The hypoxia-induced increase of 257
Hif1α then induces multiple adaptations through gene expression (126). During exercise, 258
hypoxia-induced signalling is also at work. For example, HIF1α levels increase in response 259 to normoxic endurance exercise (5). Moreover, altitude training is often used to stimulate the 260 molecular adaptations to hypoxia, including the EPO-mediated haematopoiesis that 261 increases the athlete's oxygen transport capacity (118) . 262
263
Hypoxia and Hippo signalling also interact. For example, hypoxia activates the E3 ligase 264
Siah2, which leads to the degradation of Lats2. This results in a decreased level of Yap 265 phosphorylation, increasing the activity of Yap in the nucleus (88). Additionally, Yap directly 266 interacts with and stabilises Hif1α (88). Hif1α also promotes the expression of Taz and Taz  267 transactivates Hif1α, highlighting a mechanism by which Taz and Hif1α are acting as 268 reciprocal co-activators (153). It is unknown whether hypoxia-Hippo mechanisms function 269 during normoxic endurance exercise (5) and mediate adaptations to high altitude or low-270 intensity occlusion training. Direct evidence in an exercise or altitude model is required. 271
272

Sensing of catecholamines and other G protein-coupled receptors (GPCRs) ligands 273 by Hippo 274
Catecholamines, such as adrenaline (US: epinephrine) and noradrenaline (US: 275 norepinephrine), mediate the "fight-or-flight" responses. Catecholamine concentrations 276 generally increase with the intensity and duration of exercise and drive the systemic 277 responses to exercise via the α-and β-adrenergic receptors. These receptors, in turn, signal 278 through G-protein coupled receptors (GPCRs) to trigger exercise adaptations, such as 279 increasing the heart rate and muscle contractility. Moreover, β2 agonists such as clenbuterol 280 promote skeletal muscle hypertrophy, suggesting an involvement of this system in the 281 control of skeletal muscle growth (89). In the renin-angiotensin system (RAS), the 282 angiotensin receptors are also coupled to protein G. The RAS was related to exercise when 283 the ACE I/D polymorphism was associated with exercise-related traits, such as strength and 284 endurance (111). Also, angiogensin II contributes to the adaptation to overload-induced 285 skeletal muscle hypertrophy (47) and stretch-induced cardiac hypertrophy (112). In 286 accordance with this, the ACE I/D polymorphism was associated with the left ventricular 287 mass changes occurring in response to endurance training (103). 288
289
Multiple studies have linked GPCRs to Hippo signalling. Adrenaline/epinephrine represses 290 YAP/TAZ through Gα S -coupled GPCRs and protein kinase A (PKA) (74, 158) . In contrast, 291 angiotensin II and other ligands signal through the Gα 12/13 and Gα q/11 GPCRs to activate 292 YAP/TAZ (150, 160). Given that Yap has been shown to mediate skeletal muscle 293 hypertrophy (46, 148) and can promote cardiac hypertrophy (reviewed in (141)), it will be key 294 to test whether GPCR-Hippo signalling is involved in mediating such adaptations. 295 296
Interleukin-6 and Hippo 297
Interleukin-6 is a myokine (i.e. a circulating signalling molecule) that is produced by 298 contracting muscle but whose functions are incompletely understood (106, 110) . Recently, 299 interleukin-6 has been shown to activate Yap through the gp130 co-receptor in the intestine 300 (125). However, it remains unclear whether this mechanism explains some of the effects of 301 exercise-generated interleukin-6. 302
303
Hippo & exercise-related phenomena 304
In the text above we have shown that many resistance and endurance exercise-associated 305 signals can cross-talk to the Hippo signal transduction network (see Figure 1) . However, 306 much of this evidence was obtained in the context of cancer or non-exercise contexts. In the 307 following section, we will review a small number of studies that provide evidence for a role of 308
Hippo signalling in the adaptation to exercise. In relation to this, some key findings are 309 summarised in Table 1 Cardiomyocyte proliferation ↑;
relative heart weight ↑; regulation of cell cycle-related genes.
Salvador: Inducible, Myh6-driven Cardiac proliferation, 
rAAV, recombinant adeno-associated virus; Nkx2.5 and Tnnt2 are promoters used to drive 315 the specific expression of genes in cardiomyocytes. 316
317
Hippo and adaptive changes in skeletal muscle fibre phenotypes 318
Gollnick and Saltin were the first to demonstrate a higher percentage of slow type 1 muscle 319 fibres and a higher oxidative activity in the muscles of endurance athletes when compared to 320 controls and other athletes (44). They also observed a non-significant increase from 32% to 321 36% in the frequency of slow type 1 fibres in response to endurance training (43). 322 Subsequent research has shown that chronic exercise training programmes mainly induce 323 type 2X-to-2A interconversions (151) . 324
325
In the early 2000's, the Tsika group investigated the role of MCAT elements and Tead1 326 transcription factors in the regulation of muscle fibre type-specific gene expression (71, 131, 327 140) . The functional relevance of this work was demonstrated in vivo using a creatine kinase 328 muscle (CKM) promoter to overexpress Tead1 in mouse skeletal muscle fibres, which 329 caused an increased in slow muscle-specific gene expression in vivo (Table 1 , (132)). 330
Functionally, CKM-driven Tead1 overexpression reduced the shortening velocity (Vmax) and 331 increased the contraction and relaxation times of extensor digitalis longus muscles (132) . 332 This suggests that Hippo signalling affects muscle fibre type-specific gene expression and 333 fibre type percentages. 334
335
Hippo and skeletal muscle hypertrophy 336
Muscle hypertrophy is a key response to resistance exercise. After resistance exercise, 337 protein synthesis and protein breakdown both increase. In the fed state, protein synthesis is 338 higher than breakdown, resulting in protein accretion and hypertrophy (128). However, the 339 effect of resistance exercise on muscle hypertrophy and strength differs greatly among the 340 human population (64). A key mediator of muscle protein synthesis is mTOR signalling, as 341
shown for example by the inhibitory effect of rapamycin on the increase of muscle protein 342 synthesis after resistance exercise in human muscles (30). The key effect of resistance 343 exercise on muscles is mechanical loading, which was discussed in the first part of this 344 review along with the extensive links between mechanosensing and Hippo signalling 345 (reviewed in (50, 87)), including the Z-disc located Bag3 mechanosensor in skeletal muscle 346 (135, 136) . 347
348
Several studies support a link between Hippo signalling, resistance exercise and muscle 349 fibre size. In the first study on Hippo signalling in relation to exercise, the Booth group used 350 chronic stretch overload to induce hypertrophy of the anterior latissimus dorsi muscle and 351
found an increased expression of the skeletal α-actin gene. They showed that stretch 352 overload activated a CATTCC (MCAT) motif-containing luciferase reporter, suggesting that 353
Tead transcription factor activity was present during mechanical overload of skeletal muscle 354 (19). In a human study, eight men performed 100 unilateral maximal drop jumps followed by 355 submaximal jumping until exhaustion (75). The mRNA of the Hippo pathway marker genes 356 cysteine-rich angiogenic protein 61 (CYR61) and connective tissue growth factor (CTGF) 357 (77, 164) increased 14-and 2.5-fold 30 min after exercise, respectively. Additionally, CYR61 358 protein levels were approximately 2-fold higher at both 30 min and 48 h after the exercise 359 compared with resting control levels. This suggests that some forms of mechanical loading 360 can induce the expression of Hippo marker genes. However, it is unclear whether the 361 increases of CYR61 and CTGF expression are a direct consequence of altered Hippo 362
signalling. 363 364
Two recent studies linked Yap activity directly to muscle fibre hypertrophy. Watt in the 365
Harvey group used an adeno-associated viral vector (rAAV6)-mediated shRNA knock down 366 strategy to reduce Yap levels in mouse limb muscles. They found a decreased muscle fibre 367 size and reduced protein synthesis (148). Additionally, they used the same rAAV6 system to 368 over express the predominant YAP isoform in muscle and found increases in muscle mass, 369 cross sectional area and protein synthesis (Table 1 , (148)). Intriguingly, despite the 370 extensive evidence of cross-talk between Hippo and mTOR signalling discussed in the first 371 part of this review, their YAP interventions did not seem to affect mTOR activity. In another 372 study, the Hornberger group reported that YAP expression increases up to approximately 373 4.5 folds in the hypertrophying plantaris muscle days synergist ablation, a model commonly 374 used to induce skeletal muscle hypertrophy (46). Then, they used electroporation to 375 overexpress YAP in the tibialis anterior muscles and analysed the muscles 7 days later. The 376 fibres overexpressing YAP were larger than control fibres, demonstrating that elevated YAP 377 activity could cause hypertrophy (Table 1) The maximal oxygen uptake (VO 2 max) is the key determinant of an individual's endurance 419 capacity (27) and is also associated with longevity (15). Early physiological studies in 420 humans demonstrated that one of the key predictors of an individual's VO 2 max is the blood 421 flow generated by the heart, termed cardiac output (99), which determines the efficiency of 422 oxygen transport to the exercising musculature. The VO 2 max and cardiac output parameters 423 respond to exercise training and detraining, as demonstrated by Saltin and colleagues (113). 424
They showed that 20 days of bed rest reduces resting heart volume by approximately 10% 425 and exercise cardiac output by 15%, resulting in a significantly reduced VO 2 max (113). 426
Conversely, 55 days of endurance exercise training following the bed rest increased cardiac 427 output above pre-bed rest levels. This partially explains the restoration of VO 2 max (142). 428
429
The increase in cardiac output can be attributed to the development of an athlete's heart in 430 response to endurance training. Indeed, electrocardiographic studies show that athletes 431 have enlarged hearts (9) which was later confirmed by comparative echocardiography on 432 endurance athletes (91). Generally, the main cellular mechanism underlying the athlete's 433 heart is cardiomyocyte hypertrophy. For example endurance running training for 8 weeks 434
increases cardiomyocyte size by 17-32% in mice (73). Until several years ago, researchers 435 thought that adult cardiomyocytes were unable to proliferate and regenerate the heart. 436
However, this view is now changing (33). By determining the levels of suggesting that exercise promotes cardiomyocytes proliferation, at least in mice. There is 442 emerging evidence supporting the existence of a cardiac stem cell population that may 443 engage in some limited regeneration processes (32) in addition to a low rate renewal of pre-444 existing cardiomyocytes (119). Two recent studies found that both cardiac stem cells and 445 cardiomyocytes proliferate in response to endurance exercise in rodents (80, 146) . 446
Collectively, these data demonstrate that endurance exercise increases left ventricular 447 volume, thickness and pumping performance and suggest that these effects occur mainly 448 through cardiomyocyte hypertrophy with a limited contribution of cardiac stem cells and 449 cardiomyocytes proliferation. Consequently, this results in the development of the athlete's 450 heart, which in turn increases the VO 2 max and aerobic exercise capacity of an individual. 451
452
The heart can respond to increased load in two different ways, depending upon the nature of 453 the load (94): 454 1) Physiological hypertrophy (i.e., athlete's heart) can occur as a response to endurance 455 exercise or pregnancy (volumetric hypertrophy) or resistance exercise (non-volumetric 456 hypertrophy); 457 2) Pathological hypertrophy can occur after cardiac injury or in individuals with high blood 458 pressure or defective valves. 459
460
Physiological hypertrophy, which is associated with exercise or pregnancy, differs from 461 pathological hypertrophy by the nature of the stimuli, the structural response, the absence of 462 fibrosis and the molecular drivers leading to the adaptation (94). Generally, physiological 463 hypertrophy does not progress into cardiac dysfunction. In contrast, pathological hypertrophy 464 often decompensates, reducing cardiac function and resulting in end-stage heart failure (72). of-function in the embryonic heart is frequently lethal (reviewed by (84, 141, 155) ). This 471 suggests that normal Yap function is essential for normal cardiac development. Presumably, 472
Yap is active only in certain cell populations during specific periods, which could explain why 473 permanent Yap gain-or loss-of-function has such a detrimental effect. There is some 474 evidence that Hippo signalling is perturbed during pathological cardiac hypertrophy. Yap is 475 expressed at higher levels and dephosphorylated (activated) in samples obtained from 476 pathologically hypertrophied human hearts (144). Furthermore, Yap is activated in hearts 477 stressed by pathological pressure overload (144) and in the area bordering a myocardial 478 infarction in mice (25). 479
480
Are Hippo members contributing to the formation of the athlete's heart in response to 481 exercise? Although this question has not been addressed directly, published data suggest 482 possible roles for Hippo members in mediating the athlete's heart (see also The reasons behind these contrasting results are unknown and so it is unclear whether 487
Hippo signalling contributes to cardiomyocyte hypertrophy in response to exercise (73). 488 489
Another response of the heart to endurance exercise is the limited proliferation of 490 cardiomyocytes and cardiac stem cells in rodents (16, 80, 146 (23, 57, 78, 152) . In the largest meta-analysis study using data obtained from 253,288 525 individuals of recent European ancestry (152), body height-associated SNPs in LATS2 526 (rs1199734), TEAD1 (rs6485978, rs2099745), VGLL2 (rs1405212) and VGLL4 (rs13078528) 527 were identified. In 2010, Lango Allen et al. identified an association between SNPs in TEAD1 528 (rs7926971) and VGLL2 (rs961764) with body height in 133,653 individuals of recent 529
European ancestry. Also, SNPs in YAP1 (rs11225148) and in VGLL3 (rs7628864) were 530 individually associated with a shorter stature during pubertal growth in a longitudinal meta-531 analysis involving 18,737 European individuals (23). Interestingly, the SNP in VGLL3 was 532 only significantly associated with the trait in females. So far, no sex-related differences were 533 reported for the Hippo pathway functions but this association could suggest that such 534 differences might actually exist in some contexts. Finally, a SNP in VGLL4 (rs6772112) was 535 associated with height in 36,227 East Asian ancestry subjects (57). Another interesting 536 association of the study by Cousminer et al. is the identification of a female-specific SNP in 537 LIN28B associated with late pubertal growth (23). The LIN28/LET-7 pathway, which has 538 recently emerged as a potent regulator of organismal development and cellular metabolism 539 (120), has been functionally linked with the Hippo pathway (21, 104). In summary, common 540 DNA sequence variants in several Hippo genes influence body height but the effect of each 541 variant on height is small, presumably as de novo DNA sequence variants with a large effect 542 size either become fixed or lost relatively quickly (17). 543 544
Summary and future research 545
In this review, we have listed mainly indirect evidence suggesting that Hippo signalling may 546 mediate some of the physiological adaptations to exercise and that SNPs, especially in the 547
Hippo transcriptional regulators, are associated with body height as a measure of whole 548 24 body cell numbers. The task for molecular exercise physiologists is now to directly show that 549 these mechanisms mediate adaptation to exercise in exercise models and that Hippo gene 550 variants are associated with sport and exercise-related traits. We end with three questions: 551 1) Because resistance and endurance exercise trigger different adaptations in skeletal 552 muscle, how can it be explained that the activity of Hippo members is both affected by 553 both resistance and endurance exercise-associated signals? 554
2) Given that Hippo signalling affects amino acid (52) and glucose transporter expression 555 (145), can this be used to develop strategies to alter the responsiveness to nutrients? 556
For example, can we target through Hippo modulation the leucine transporter LAT1 (52) 557 to make muscles and other organs more sensitive to protein intake ? Could such 558 strategy be beneficial for strength athletes or in cases of muscle weakness and wasting, 559 for example, in elderly individuals or cancer patients with sarcopenia? 560 3) Given that the Hippo pathway is involved in regulating the fate of many stem cells (129), 561 can this be exploited to develop interventions aimed at improving the repair of muscle, 562 tendons and cartilage after sports injury or in degenerative muscle diseases? 563
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